Gassen William 4

What Happened

• William Gassen, a director of HealthEquity, was granted 2,877 restricted stock units (RSUs) on June 25, 2026. The Form 4 reports the acquisition price as $0.00 (this is an award/grant, not a cash purchase), and total reported value on the form is $0.00. These RSUs convert to one share each upon vesting.

Key Details

• Transaction date and code: 2026-06-25 — Code A (award/grant).
• Shares/units granted: 2,877 RSUs; reported acquisition price: $0.00.
• Vesting: RSUs vest in full on the earlier of (i) June 25, 2027 or (ii) the issuer’s next annual stockholder meeting in June 2027; vested shares will be delivered upon vesting (Footnote F1).
• Shares owned after transaction: not specified in the provided filing.
• Filing timeliness: Form filed 2026-06-29 (appears timely); Power of Attorney referenced was previously filed (March 30, 2026) and is incorporated by reference.

Context

• RSUs are a form of equity compensation that give the holder a contingent right to receive shares if/when they vest; they are common for directors and typically reflect compensation rather than an active market purchase or sale. Because this is an award (not a purchase or sale), it should be viewed as routine compensation disclosure rather than a direct signal of insider buying or selling.